![]() Pharmaron Pharmaron (康龙化成(北京)新药技术股份有限公司) is a company that provides contract research, development, and manufacturing services for pharmaceutical products. | ![]() BBCA Group BBCA Group (丰原集团, also known as Anhui Fengyuan Group) is a biological fermentation technology company. | ![]() WuXi AppTec WuXi AppTec (药明康德, formerly known as WuXi PharmaTech) is a company providing research, development, and manufacturing services to discover and manufacture small molecule drugs and cell and gene therapies. | ![]() Akums Akums Drugs & Pharmaceuticals is a company that provides contract research and manufacturing services. | ![]() Lotus Pharmaceutical Lotus Pharmaceutical (美時) is a generic company that develops, manufactures, and markets pharmaceutical products. | ![]() Samsung Biologics Samsung Biologics (삼성바이오로직스) is a contract development and manufacturing organization. | |
Founding Date | Founding Date 2004 | Founding Date 1958 | Founding Date 2000 | Founding Date 2004 | Founding Date 1966 | Founding Date 2011 |
Type | Type Public | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | ||||||
Locations | Locations Bengbu Shi, CN HQ São Paulo, BR | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Guangzhou, CN Nantong, CN Shanghai, CN see more | Locations Delhi, IN HQ Delhi, IN | Locations Taipei City, TW HQ Singapore, SG Ho Chi Minh City, VN | Locations Incheon, KR HQ Boston, US Ridgefield Park, US South San Francisco, US | |
Employees | Employees 20,295 | Employees 8,000 | Employees 41,1168% increase | Employees 4,2091% increase | Employees 1,099 | Employees 4,523 |
Valuation ($) | Valuation ($) 6.7 b | Valuation ($) N/A | Valuation ($) 20.7 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||||
Revenue (est.) | Revenue (est.) ¥11.5b (FY, 2023) | Revenue (est.) N/A | Revenue (est.) ¥40b (FY, 2023) | Revenue (est.) N/A | Revenue (est.) NT$17b (FY, 2023) | Revenue (est.) ₩3.7t (FY, 2023) |
Cost of goods | Cost of goods ¥7.4b (FY, 2023) | Cost of goods N/A | Cost of goods ¥23.7b (FY, 2023) | Cost of goods N/A | Cost of goods NT$6.3b (FY, 2023) | Cost of goods ₩1.9t (FY, 2023) |
Gross profit | Gross profit ¥4b (FY, 2023) | Gross profit N/A | Gross profit ¥16.3b (FY, 2023) | Gross profit N/A | Gross profit NT$10.7b (FY, 2023) | Gross profit ₩1.8t (FY, 2023) |
Net income | Net income ¥1.6b (FY, 2023) | Net income N/A | Net income ¥9.7b (FY, 2023) | Net income N/A | Net income NT$4.1b (FY, 2023) | Net income ₩857.7b (FY, 2023) |
Funding | ||||||
Total funding raised | Total funding raised $ 909m | Total funding raised N/A | Total funding raised $ 902.6m | Total funding raised $ 70m | Total funding raised N/A | Total funding raised N/A |
BBCA Group (丰原集团, also known as Anhui Fengyuan Group) is a biological fermentation technology company.
View companyWuXi AppTec (药明康德, formerly known as WuXi PharmaTech) is a company providing research, development, and manufacturing services to discover and manufacture small molecule drugs and cell and gene therapies.
View companyAkums Drugs & Pharmaceuticals is a company that provides contract research and manufacturing services.
View companyLotus Pharmaceutical (美時) is a generic company that develops, manufactures, and markets pharmaceutical products.
View company